Kenneth B. Adler
Corporate Officer/Principal bij North Carolina State University
Profiel
Kenneth B.
Adler is the founder of BioMarck Pharmaceuticals Ltd.
which was founded in 2002.
He held the title of Chief Scientist.
Currently, Dr. Adler is a Professor at North Carolina State University.
Dr. Adler received a doctorate degree from the University of Vermont.
Actieve functies van Kenneth B. Adler
| Bedrijven | Functie | Begin |
|---|---|---|
| North Carolina State University | Corporate Officer/Principal | - |
Eerdere bekende functies van Kenneth B. Adler
| Bedrijven | Functie | Einde |
|---|---|---|
BioMarck Pharmaceuticals Ltd.
 BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Oprichter | - |
Opleiding van Kenneth B. Adler
| University of Vermont | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Health Technology |
